Hirasawa Y - Search Results

1

[Clinical evaluation of Kr-81m inhalation study through a dead space].

Kurosawa H, Matsubayashi S, Ishii Y, Ishida H, Hirasawa Y, Mori Y, Shimada T, Kawakami K. Kurosawa H, et al. Among authors: hirasawa y. Kaku Igaku. 1990 Feb;27(2):125-31. Kaku Igaku. 1990. PMID: 2348581 Japanese.

2

[Pulmonary distribution of 99mTc-technegas--a comparative study of radioactive inert gases].

Kawakami K, Shimada T, Tominaga S, Mori Y, Goto E, Hirasawa Y. Kawakami K, et al. Among authors: hirasawa y. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Oct;30(10):1781-7. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1334523 Japanese.

3

[Kinetics and clinical application of 99mTc-technegas].

Kawakami K, Iwamura A, Goto E, Mori Y, Abe T, Hirasawa Y, Ishida H, Shimada T, Tominaga S. Kawakami K, et al. Among authors: hirasawa y. Kaku Igaku. 1990 Jul;27(7):725-33. Kaku Igaku. 1990. PMID: 2172605 Japanese.

4

Pharmacological profile of FR260330, a novel orally active inducible nitric oxide synthase inhibitor.

Chida N, Hirasawa Y, Ohkawa T, Ishii Y, Sudo Y, Tamura K, Mutoh S. Chida N, et al. Among authors: hirasawa y. Eur J Pharmacol. 2005 Feb 10;509(1):71-6. doi: 10.1016/j.ejphar.2004.12.028. Eur J Pharmacol. 2005. PMID: 15713431

5

Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue.

Hirasawa Y, Nishio M, Maeda K, Yoshida K, Kita Y. Hirasawa Y, et al. Eur J Pharmacol. 1995 Jan 5;272(1):39-43. doi: 10.1016/0014-2999(94)0062s-5. Eur J Pharmacol. 1995. PMID: 7713147

6

FR144420, a novel, slow, nitric oxide-releasing agent.

Kita Y, Ohkubo K, Hirasawa Y, Katayama Y, Ohno M, Nishino S, Kato M, Yoshida K. Kita Y, et al. Among authors: hirasawa y. Eur J Pharmacol. 1995 Mar 6;275(2):125-30. doi: 10.1016/0014-2999(94)00750-2. Eur J Pharmacol. 1995. PMID: 7796846

7

Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.

Kita Y, Hirasawa Y, Maeda K, Nishio M, Yoshida K. Kita Y, et al. Among authors: hirasawa y. Eur J Pharmacol. 1994 May 12;257(1-2):123-30. doi: 10.1016/0014-2999(94)90703-x. Eur J Pharmacol. 1994. PMID: 8082692

8

Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent.

Hirasawa Y, Sugimoto T, Fukuyama S, Kato Y, Takamatu H, Ohno M, Nishino S, Kato M, Maeda K, Seki J, Kita Y. Hirasawa Y, et al. Eur J Pharmacol. 1996 May 6;303(1-2):55-9. doi: 10.1016/0014-2999(96)00105-7. Eur J Pharmacol. 1996. PMID: 8804911

9

In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.

Kato Y, Kita Y, Nishio M, Hirasawa Y, Ito K, Yamanaka T, Motoyama Y, Seki J. Kato Y, et al. Among authors: hirasawa y. Eur J Pharmacol. 1999 Nov 19;384(2-3):197-202. doi: 10.1016/s0014-2999(99)00658-5. Eur J Pharmacol. 1999. PMID: 10611442

10

Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives.

Fukuyama S, Hirasawa Y, Kato Y, Nishio M, Ohno M, Nishino S, Maeda K, Kato M, Kita Y. Fukuyama S, et al. Among authors: hirasawa y. J Pharmacol Exp Ther. 1997 Jul;282(1):236-42. J Pharmacol Exp Ther. 1997. PMID: 9223559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

686 results

Search Page

Filters